Abcam’s (ABC) “Hold” Rating Reaffirmed at Peel Hunt
Abcam (LON:ABC)‘s stock had its “hold” rating reissued by stock analysts at Peel Hunt in a research report issued to clients and investors on Thursday.
Separately, Numis Securities reiterated a “hold” rating on shares of Abcam in a report on Tuesday, September 11th.
Abcam stock opened at GBX 1,062 ($13.88) on Thursday. Abcam has a 1-year low of GBX 9.73 ($0.13) and a 1-year high of GBX 1,290 ($16.86).
Abcam Company Profile
Abcam plc, together with its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company primarily offers primary and secondary antibodies; ELISA, matched antibody pairs and multiplex immunoassays; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex miRNA assays.
Receive News & Ratings for Abcam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam and related companies with MarketBeat.com's FREE daily email newsletter.